Erudio Healtherudio.com
Clinical trial · no report yet · Phase 1
NCT06874335 trial: what clinicians have said so far
A Phase 1 Study of BHV-1530 in Advanced Solid Tumors
- NCT06874335 ↗
- Recruiting
- Biohaven Therapeutics Ltd.
- Focused size, estimated: 1–150 verified statements once built
We haven't built an HCP commentary report on NCT06874335 (BHV-1530; BHV-1530 plus cemiplimab in advanced or metastatic solid tumors) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on NCT06874335 so far
Podcasts, YouTube videos and posts on X and Bluesky we have indexed that name the trial. LinkedIn posts are read for reports and the Enterprise MCP, not yet for this index. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Indexed so far | |
|---|---|
| 4 posts on X, typically up to 18 once built |
The trial
ClinicalTrials.gov- Official title
- A Phase 1, Multicenter, Open-Label, Dose Escalation, Dose Expansion and Dose Optimization Study of BHV-1530 as Monotherapy and in Combination With Other Anti-Cancer Agents in Adult Participants With Advanced or Metastatic Solid Tumors
- Phase
- Phase 1
- Status
- Recruiting
- Conditions
- Solid Tumor
- Interventions
- BHV-1530; Cemiplimab
- Arms
- BHV-1530 Monotherapy · Experimental
- Experimental: BHV-1530 in combination with Cemiplimab · Experimental
- Enrollment
- 140 (estimated)
- Primary outcomes
- Dose-escalation and Dose-expansion Cohorts: To determine the safety profile, maximum tolerable dose (MTD), minimally reproducible active dose (MRAD), and recommended dose range (RDR) of BHV-1530 monotherapy and BHV-1530 in combination with cemiplimab
- Dose-optimization Cohorts: Recommended dose of BHV-1530 for later phase trials
- Sponsor
- Biohaven Therapeutics Ltd.
- Start
- Mar 20, 2025
- Primary completion
- Mar 2029 (estimated)
- Results posted
- No
- Registry record
- NCT06874335 · updated Jul 9, 2026